ADRs monitoring and analysis of cardiovascular drugs

Xinping Zhang,Yongming Wang,BinYan Chen
1996-01-01
Abstract:Objective: To evaluate the incidence and risk factors of cardiovascular drugs-related ADRs. Methods: Patients hospitalized in Zhongshan and Huashan hospitals in a year, who took one or more kinds cardiovascular drugs, were observed prospectively. Results: Of the 1015 patients, 108 (10.64%) had ADRs. The incidence of 8 drugs was 3.36% (propafenone), 3.9% (diltiazem), 4.26% (nifedipine), 5.62% (captopril), 7.16% (digoxin), 10.86% (mexiletine), 3.52% (atenolol), and 4.90% (metoprolol) respectively. Type A and B reactions accounted for 90.74% and 9.26% respectively in all ADRs patients. 34 patients (31.84%) discontinued treatment. Logistic analysis showed that the number of drugs and kidney function are closely related to ADRs. Conclusion: The incidence of cardiovascular drug-related ADRs is 10.64%. Logistic analysis helps determine risk factors of ADRs.
What problem does this paper attempt to address?